Phasebio Pharmaceuticals Inc (PHAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | PHAS | GOVX | CYCC | ||
Company | Phasebio Pharmaceuticals Inc | Geovax Labs | Cyclacel Pharmaceuti | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 0.0800 | 1.4200 | 2.37 | ||
High | 0.0920 | 1.7000 | 2.52 | ||
Low | 0.0665 | 1.4200 | 1.94 | ||
Last | 0.0701 | 1.6100 | 2.00 | ||
Change | -0.0249 | +0.1900 | -0.49 | ||
% Change | -26.21% | +13.38% | -19.68% | ||
Volume | 9,647,400 | 141,300 | 566,900 | ||
20-Day Average Volume | 3,930,150 | 29,490 | 2,372,155 | ||
Previous Close | 0.0950 | 1.4200 | 2.49 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 0.1610 | 1.5900 | 1.92 | ||
20-Day Raw Stochastic | 2.27% | 34.85% | 25.93% | ||
20-Day Relative Strength | 20.88% | 40.76% | 48.67% | ||
Weighted Alpha | -91.26 | -84.34 | -79.49 | ||
Today's Opinion | 100% Sell | 88% Sell | 80% Sell | ||
Previous Opinion | 100% Sell | 100% Sell | 48% Sell | ||
Last Month's Opinion | 72% Sell | 88% Sell | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -42.40% since 10/26/22 | +13.38% since 04/26/24 | +32.45% since 04/26/24 | ||
Low | 0.0665 on 11/02/22 | 1.3800 on 04/30/24 | 1.30 on 04/29/24 | ||
High | 0.1440 on 10/27/22 | 1.7000 on 05/03/24 | 4.00 on 05/01/24 | ||
1-Month | |||||
%Chg | -60.17% since 09/30/22 | -17.01% since 04/03/24 | -8.68% since 04/03/24 | ||
Low | 0.0665 on 11/02/22 | 1.3800 on 04/30/24 | 1.30 on 04/29/24 | ||
High | 0.2250 on 10/14/22 | 2.1499 on 04/04/24 | 4.00 on 05/01/24 | ||
3-Month | |||||
%Chg | -93.85% since 08/02/22 | -45.77% since 02/02/24 | -10.31% since 02/02/24 | ||
Low | 0.0665 on 11/02/22 | 1.3800 on 04/30/24 | 1.30 on 04/29/24 | ||
High | 1.3800 on 08/09/22 | 2.9400 on 02/12/24 | 4.00 on 05/01/24 | ||
6-Month | |||||
%Chg | -94.35% since 05/02/22 | -79.64% since 11/03/23 | -77.05% since 11/03/23 | ||
Low | 0.0665 on 11/02/22 | 1.3800 on 04/30/24 | 1.30 on 04/29/24 | ||
High | 1.3800 on 08/09/22 | 8.5500 on 11/08/23 | 10.12 on 11/06/23 | ||
Key Statistics | |||||
Market Capitalization, $K | 3,495 | 3,716 | 2,637 | ||
Shares Outstanding, K | 49,858 | 2,308 | 1,318 | ||
Annual Sales | 10,830,000 | 0 | 420,000 | ||
Annual Net Income | -131,070,000 | -25,970,000 | -22,560,000 | ||
Last Quarter Sales | 210,000 | 0 | 30,000 | ||
Last Quarter Net Income | -16,670,000 | -7,590,000 | -5,270,000 | ||
60-Month Beta | 2.57 | 2.91 | 0.54 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.34 on 08/12/22 | -4.80 on 11/08/23 | -6.23 on 03/19/24 | ||
Latest Earnings Date | 11/09/22 | 05/02/24 | 05/09/24 | ||
Most Recent Dividend | N/A | N/A | 0.150 on 07/13/16 | ||
Next Ex-Dividends Date | N/A | N/A | 07/13/16 | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |